2024 U.K. Coagulation Testing Market--Hemostasis Analyzers and Consumables--2023 Supplier Shares, 2023-2028 Segment Volume and Sales Forecasts for over 40 Coagulation Assays, Opportunities for Suppliers--Molecular, Chromogenic and Immunodiagnostic Hemostasis Tests--Growth Strategies, Latest Technologies, Instrumentation Pipeline
Summary This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market during the next five years.The report is available by section, and can be customized to specific information needs and budget.The report explores business and technological trends in the UK coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's, Factor Fav/Ag, and others.Sales and Market Share Analysis%li%Sales and market shares of major instrument and reagent suppliers.Competitive Assessments%li%Extensive strategic profiles of major suppliers and emerging market entrants.Market Segmentation Analysis%li%Comprehensive market segmentation analysis, including:Hospitals, Commercial/Private Laboratories%li%Test volume forecasts for over 40 major procedures by market segment.Current and Emerging Products%li%Review of established and emerging procedures.%li%Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.Technology Review%li%Analysis of current and emerging technologies and their potential market applications.%li%Comprehensive lists of companies developing or marketing new technologies and products by test.Strategic Recommendations%li%Product development and business expansion opportunities with significant market appeal.%li%Ideal product models with tentative prices and operating characteristics.%li%Alternative market penetration strategies for instrument and reagent suppliers.%li%Potential market entry barriers and risks.
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. INTRODUCTION
2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
3. ALPHA-2 ANTIPLASMIN
4. ANTITHROMBIN III
5. BLEEDING TIME
6. D-DIMER
7. ETHANOL FLOCCULATION TEST
8. EUGLOBULIN LYSIS
9. FACTOR ASSAYS
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. FIBRIN DEGRADATION PRODUCTS
11. FIBRINOGEN
12. HEPARIN
13. HIRUDIN
14. HYPERCOAGULABILITY AND THROMBOSIS
15. LIPOPROTEIN A
16. PLASMIN
17. PLASMINOGEN
18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)
19. PLATELET FUNCTION TESTS
20. PLATELET AGGREGATION
21. PROTEINS C AND S
22. PROTHROMBIN FRAGMENT 1.2
23. PROTHROMBIN TIME (PT)
24. REPTILASE TIME
25. THROMBIN TIME
26. TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA)
27. VON WILLEBRAND'S FACTOR
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their
Potential Applications
1. CHROMOGENIC SUBSTRATES
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. MOLECULAR DIAGNOSTICS
5. MICROCOMPUTERS
6. AUTOMATION
7. ROBOTICS
8. ARTIFICIAL INTELLIGENCE
9. DRY CHEMISTRY
10. BIOSENSORS
III. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument
and Reagent Suppliers’ Sales and Market Shares
IV. Major Product Development Opportunities
V. Design Criteria For Decentralized Testing Products
II. Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. INTRODUCTION
2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
3. ALPHA-2 ANTIPLASMIN
4. ANTITHROMBIN III
5. BLEEDING TIME
6. D-DIMER
7. ETHANOL FLOCCULATION TEST
8. EUGLOBULIN LYSIS
9. FACTOR ASSAYS
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. FIBRIN DEGRADATION PRODUCTS
11. FIBRINOGEN
12. HEPARIN
13. HIRUDIN
14. HYPERCOAGULABILITY AND THROMBOSIS
15. LIPOPROTEIN A
16. PLASMIN
17. PLASMINOGEN
18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)
19. PLATELET FUNCTION TESTS
20. PLATELET AGGREGATION
21. PROTEINS C AND S
22. PROTHROMBIN FRAGMENT 1.2
23. PROTHROMBIN TIME (PT)
24. REPTILASE TIME
25. THROMBIN TIME
26. TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA)
27. VON WILLEBRAND'S FACTOR
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their
Potential Applications
1. CHROMOGENIC SUBSTRATES
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. MOLECULAR DIAGNOSTICS
5. MICROCOMPUTERS
6. AUTOMATION
7. ROBOTICS
8. ARTIFICIAL INTELLIGENCE
9. DRY CHEMISTRY
10. BIOSENSORS
III. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument
and Reagent Suppliers’ Sales and Market Shares
IV. Major Product Development Opportunities
V. Design Criteria For Decentralized Testing Products
